3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
106
Terminated
30
Recruiting
28
Active not recruiting
20
Unknown
7
Withdrawn
4
Enrolling by invitation
3
Suspended
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
3
OTHER
2
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Genitourinary
3
Thoracic
1
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
12
Hematologic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
5
Urinary Bladder Neoplasms
4
Leukemia, Myeloid, Acute
4
Colorectal Neoplasms
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Myasthenia Gravis
3
Multiple Myeloma
3
Lung Neoplasms
3
Kidney Neoplasms
3
Carcinoma, Hepatocellular
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Heart Failure
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Diabetes Mellitus, Type 2
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
INDUSTRY
×
Kidney Neoplasms
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled
NCT06945640
2025-09-16
HTK_002
Hutom Corp
Phase NA
Enrolling by invitation
80 enrolled
NCT02609269
2023-02-17
GRID®
GenomeDx Biosciences Corp
Enrolling by invitation
1,000,000 enrolled